Education
About Us
Working with TipRanks
Follow Us
PKW - ETF AI Analysis
Top Page
Invesco Buyback Achievers ETF (PKW)
Rating:70Outperform
Price Target:
$143.00
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Goldman Sachs and HCA Healthcare, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Financials, Consumer Cyclical, and Health Care, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The fund has shown solid year-to-date growth, indicating strong momentum in its portfolio.
Negative Factors
High Geographic Concentration
With nearly 96% of its holdings in U.S. companies, the ETF lacks significant international exposure, increasing vulnerability to domestic market risks.
Underperforming Holdings
Some key positions, like PayPal and Fiserv, have struggled with negative year-to-date performance, potentially dragging down overall returns.
Above-Average Expense Ratio
The ETF's expense ratio of 0.62% is higher than many low-cost alternatives, reducing net returns for investors.
PKW vs. SPDR S&P 500 ETF (SPY)
AUM1.48B
RegionNorth America
Expense Ratio0.62%
Beta0.89
IssuerInvesco
Inception DateDec 20, 2006
Dividend Yield0.99%
Asset ClassEquity
Index TrackedNASDAQ US Buyback Achievers Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume25,636
30 Day Avg. Volume32,116
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
152.87Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering211
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PKW Summary
The Invesco Buyback Achievers ETF (PKW) is a fund that invests in U.S. companies known for buying back their own shares, which is often a sign of financial strength and a focus on rewarding shareholders. It follows the NASDAQ US Buyback Achievers Index and includes well-known companies like Chevron and Goldman Sachs. This ETF is a good option for investors looking to diversify their portfolio while targeting companies that prioritize shareholder returns. However, new investors should be aware that its performance can fluctuate with the overall market, especially since it is heavily influenced by sectors like financials and consumer cyclical industries.
How much will it cost me?The Invesco Buyback Achievers ETF (PKW) has an expense ratio of 0.62%, meaning you’ll pay $6.20 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, focusing on companies with strong buyback strategies rather than tracking a broad index. Active management typically involves higher costs due to more frequent trading and research.
What would affect this ETF?The Invesco Buyback Achievers ETF (PKW) could benefit from strong corporate earnings and favorable tax policies that encourage share buybacks, particularly in its key sectors like Financials and Consumer Cyclical. However, rising interest rates or economic slowdowns may negatively impact buyback activity and the performance of top holdings like Chevron and Goldman Sachs, especially in sectors sensitive to economic conditions such as Energy and Financials.
PKW Top 10 Holdings
The Invesco Buyback Achievers ETF is leaning heavily on financials, with names like Goldman Sachs and Wells Fargo driving recent performance thanks to strong earnings and strategic initiatives. Healthcare stocks like HCA Healthcare and Cigna are also rising steadily, adding stability to the fund's outlook. However, PayPal and Fiserv are dragging the fund with mixed results and weak technical trends, highlighting challenges in the tech and payments space. With a clear focus on U.S. companies across diverse sectors, this ETF is a bet on shareholder-friendly firms, though its reliance on financials may leave it vulnerable to sector-specific headwinds.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Chevron | 5.23% | $76.91M | $317.37B | -2.35% | 74 Outperform | |
| Wells Fargo | 5.23% | $76.90M | $266.98B | 14.41% | 76 Outperform | |
| Goldman Sachs Group | 5.12% | $75.27M | $237.22B | 33.25% | 71 Outperform | |
| HCA Healthcare | 4.15% | $60.97M | $107.86B | 37.81% | 77 Outperform | |
| CRH plc | 3.88% | $57.01M | £55.84B | 8.22% | 76 Outperform | |
| Cigna | 3.80% | $55.81M | $72.03B | -16.13% | 72 Outperform | |
| General Motors | 3.27% | $48.02M | $65.79B | 23.63% | 75 Outperform | |
| PayPal Holdings | 3.20% | $47.05M | $58.77B | -26.82% | 78 Outperform | |
| Marathon Petroleum | 2.92% | $42.96M | $60.11B | 26.96% | 70 Outperform | |
| Monster Beverage | 2.65% | $39.00M | $69.67B | 37.13% | 80 Outperform |
PKW Technical Analysis
Negative
―
Price Trends
131.24
Negative
128.97
Negative
121.42
Positive
Market Momentum
-0.49
Positive
43.75
Neutral
52.38
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PKW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 130.77, equal to the 50-day MA of 131.24, and equal to the 200-day MA of 121.42, indicating a neutral trend. The MACD of -0.49 indicates Positive momentum. The RSI at 43.75 is Neutral, neither overbought nor oversold. The STOCH value of 52.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PKW.
PKW Peer Comparison
Comparison Results
Performance Comparison
PKW
Invesco Buyback Achievers ETF
128.94
9.50
7.95%
AVUS
Avantis U.S. Equity ETF
―
―
―
DFAU
Dimensional US Core Equity Market ETF
―
―
―
PBUS
Invesco PureBeta MSCI USA ETF
―
―
―
ONEQ
Fidelity Nasdaq Composite Index ETF
―
―
―
CGUS
Capital Group Core Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents